Building Resilient Healthcare Systems
Senior Industry Leaders Will Share Their Insights
Healthcare systems in the Middle East, Central Asia, Türkiye, Pakistan & Afghanistan are facing major challenges. The COVID-19 pandemic highlighted global health supply chain weaknesses and the region's lack of local manufacturing capabilities. Addressing many of the issues encountered - including medicine and equipment shortages, a dearth of infrastructure and resources, storage and manufacturing capabilities, untrained personnel, and weak procurement practices - provides an unprecedented opportunity to modernise existing health systems and strengthen the region’s ability to prevent, prepare and respond to future health emergencies including new pandemics and health-related vulnerabilities linked to climate change and natural disasters.
This webinar discussion, hosted by the Financial Times and IFC, explored the challenges, opportunities for localising health supplies and production in Middle East, Central Asia, Türkiye, Pakistan & Afghanistan (MCT) and identify concrete areas for action to increase resilience across the healthcare systems of the MCT region.
World-Class Business Leaders and Speakers
Manufacturing
Is there a long-term business case for regional manufacturing of medical supplies and what is the right business model?
Investment framework
How can policy makers in the region foster an enabling environment conducive to the growth of regional manufacturing? Could we see regional champions emerge on the global stage?
Healthcare
What is the role for health tech and what conditions need to be met to foster the digitization of healthcare systems in the region?
Watch On-demand
FT Live Digital Dialogues - fully digital event experiences delivering maximum engagement. Live webinars provide unique opportunities to engage global senior audiences. All access, digital passes include access to all the live sessions PLUS all sessions on demand for 30 days. Join the conversation.
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice